Valuation: Formycon AG

Market Cap 329M 379M 308M 282M 532M 36.08B 538M 3.6B 1.41B 18.03B 1.42B 1.39B 60.01B P/E 2026 *
-30.6x
P/E 2027 * 10.6x
Enterprise Value 398M 458M 372M 341M 643M 43.66B 652M 4.36B 1.71B 21.81B 1.72B 1.68B 72.61B EV / Sales 2026 *
5.47x
EV / Sales 2027 * 3.66x
Free-Float
70%
Yield 2026 *
-
Yield 2027 * -
1 day+1.13%
1 week-3.01%
Current month-2.61%
1 month-3.31%
3 months+0.65%
6 months-18.78%
Current year-27.03%
1 week 18.6
Extreme 18.6
19.54
1 month 17.68
Extreme 17.68
19.58
Current year 15.8
Extreme 15.8
26.95
1 year 15.8
Extreme 15.8
26.95
3 years 15.8
Extreme 15.8
69.6
5 years 15.8
Extreme 15.8
94.1
10 years 14.65
Extreme 14.65
94.1
Manager TitleAgeSince
Chief Executive Officer - 2022-06-30
Director of Finance/CFO 57 2023-03-31
Chief Tech/Sci/R&D Officer - 2022-06-30
Director TitleAgeSince
Director/Board Member 49 2020-12-09
Chairman 54 2024-06-11
Director/Board Member 54 2024-06-11
Date Insider Type Main position Quantity % Market Cap.
2/21/25 Buy

Chief Technology Officer

160 0.0009%
4/29/24 Buy

Executive/Senior Manager

1,200 0.0068%
4/24/24 Buy

Chief Executive Officer

2,500 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%-3.01%-27.17%-72.24% 380M
+0.93%-0.63%+3.89%+15.59% 48.57B
-0.22%+1.94%+434.22%+560.93% 41.95B
-2.82%-3.70%+29.02%+4.42% 38.85B
-0.34%+1.32%+9.32%+74.03% 37.24B
+2.47%+8.33%+15.16%+48.37% 30.67B
-1.71%-0.11%+34.23%+121.85% 16.41B
+1.46%-0.94% - - 16.1B
+0.29%+1.87%+8.17%+19.01% 13.97B
-2.13%-3.19%+3.11%-36.30% 12.62B
Average -0.11%-0.45%+56.66%+81.74% 25.67B
Weighted average by Cap. -0.17%+0.39%+87.46%+126.65%

Financials

2026 *2027 *
Net sales 72.73M 83.82M 68.11M 62.3M 118M 7.98B 119M 797M 313M 3.99B 315M 308M 13.28B 121M 140M 114M 104M 196M 13.32B 199M 1.33B 522M 6.66B 525M 514M 22.15B
Net income -10.92M -12.59M -10.23M -9.35M -17.66M -1.2B -17.89M -120M -46.95M -599M -47.25M -46.23M -1.99B 30.87M 35.57M 28.9M 26.44M 49.92M 3.39B 50.57M 338M 133M 1.69B 134M 131M 5.63B
Net Debt 69.04M 79.56M 64.65M 59.14M 112M 7.58B 113M 756M 297M 3.79B 299M 292M 12.6B 115M 132M 108M 98.42M 186M 12.61B 188M 1.26B 494M 6.3B 497M 486M 20.97B
Logo Formycon AG
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Employees
203
Date Price Change Volume
26-08-06 18.68 +0.43% 1,246
26-08-05 €18.60 -2.31% 2,889
26-08-04 €19.04 +0.21% 5,004
26-08-03 €19.00 -0.94% 3,572
26-07-31 €19.18 -0.42% 368
Trader
Investor
-
Global
-
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
18.60EUR
Average target price
39.67EUR
Spread / Average Target
+113.26%

Quarterly revenue - Rate of surprise